Mr. Steve Burrill | Chief Executive Officer
Burrill and Company

G. Steven Burrill has been involved in the growth and prosperity of the biotechnology industry for over 40 years. An early pioneer, Mr. Burrill is one of the original architects of the industry and one of its most avid and sustained developers. He currently serves as Chairman of the Board of Abunda Corporation, and is a member of the Boards of Directors of Catalyst Biosciences, Depomed (NASDAQ: DEPO), NewBridge, Proventys, Targacept (NASDAQ: TRGT) and XDx. Prior to founding Burrill & Company in 1994, he spent 28 years with Ernst & Young, directing and coordinating the firm's services to clients in the biotechnology/life sciences/high technology/manufacturing industries worldwide. In 2002, Mr. Burrill was recognized as a biotech investment visionary by the prestigious Scientific American magazine (The Scientific American 50), and in 2008 he received the BayBio Pantheon 2008 DiNA lifetime achievement award for his worldwide biotech leadership. In addition to his work with leading life science companies, Mr. Burrill is a founder and currently serves as Chairman of the Boards of the Foundation for the National Medals of Science and Technology, World Council for Ethical Standards, and Vilas County Economic Development Corporation. Additionally, he serves as Chairman of the San Francisco Mayor’s Biotech Advisory Committee (MAYBAC). Mr. Burrill also chaired the National Research Council study on linkages in biotechnology between Japan and the United States and was involved with the US-Japan Science and Technology Agreement Study of Technology Transfer Mechanisms between the US and Japan. Other not-for-profit activities include serving on the Boards of Directors of the Bay Area Science Infrastructure Consortium (BASIC), BayBio (Emeritus), California Healthcare Institute (Emeritus), The Exploratorium (Emeritus), The Kellogg Center for Biotechnology, the MIT Center for Biomedical Innovation, the National Health Museum (Vice Chairman), BIO Ventures for Global Health (BVGH), and the Scientific American Board of Advisors. He also serves on the Purdue Discovery Park External Advisory Committee as well as the editorial boards of the Journal of Commercial Biotechnology and Life Science Leader, and is on the Advisory Boards of the Center for Policy on Emerging Technologies (C-PET), SF State Dept of Biology, and BioAg Gateway - City of Madison. He is an advisor to the University of Illinois Institute for Genomic Biology, University of Wisconsin College of Agriculture & Life Sciences, University of Minnesota College of Biological Sciences, and Duke University – Institute for Genomic Science and Policy, and is an adjunct professor at University of California, San Francisco.